Codexis, Inc. (CDXS)
NASDAQ: CDXS · Real-Time Price · USD
2.820
+0.170 (6.42%)
At close: Apr 28, 2026, 4:00 PM EDT
2.818
-0.002 (-0.06%)
After-hours: Apr 28, 2026, 7:41 PM EDT
Codexis Employees
Codexis had 146 employees as of December 31, 2025. The number of employees decreased by 42 or -22.34% compared to the previous year.
Employees
146
Change (1Y)
-42
Growth (1Y)
-22.34%
Revenue / Employee
$482,103
Profits / Employee
-$301,192
Market Cap
256.25M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Coherus Oncology | 147 |
| Arcturus Therapeutics Holdings | 111 |
| C4 Therapeutics | 104 |
| Alector | 103 |
| SAB Biotherapeutics | 86 |
| Compugen | 75 |
| Cybin | 50 |
| Protara Therapeutics | 46 |
CDXS News
- 6 weeks ago - Codexis Earnings Call Transcript: Q4 2025 - Transcripts
- 6 weeks ago - Codexis Reports Fourth Quarter and Fiscal Year 2025 Financial Results - GlobeNewsWire
- 7 weeks ago - Codexis signs agreement to manufacture 50 g siRNA using its ECO Synthesis® Manufacturing Platform - PRNewsWire
- 2 months ago - Codexis Transcript: TD Cowen 46th Annual Health Care Conference - Transcripts
- 2 months ago - Codexis to Report Fourth Quarter and Fiscal Year 2025 Financial Results on March 11 - GlobeNewsWire
- 2 months ago - Codexis Achieves ISO 9001:2015 Certification - GlobeNewsWire
- 3 months ago - Codexis Expands Reach of the ECO Synthesis® Manufacturing Platform through a Signed Evaluation Agreement with Axolabs for Oligonucleotide Therapeutics - PRNewsWire
- 6 months ago - Codexis Announces Signing of Lease for GMP Manufacturing Facility - GlobeNewsWire